Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a clinical study titled A ...

Researchers assessed the quality of life measures of patients with thyroid eye disease treated with Veligrotug, a full antagonist humanized mAb to IGF-1R.

AUSTIN (KXAN) — An exceptionally rare and fatal genetic disease may finally have a solution. Huntington’s Disease affects one in ten to twenty thousand Americans. The disease is a mixture of dementia ...

A new biotechnology startup is launching with plans to challenge some of the world’s best-selling eye medicines, armed with a pair of prospects already in, or approaching, clinical testing. Called ...

Viridian Therapeutics (NASDAQ:VRDN) is a great medium term opportunity to bet on a well-differentiated next-generation therapy for Thyroid Eye Disease. Only competition is blockbuster Tepezza ...

Even hearing the phrase “Huntington’s disease” will make a room suddenly somber. So the joy that accompanied a recent announcement of results of an experimental gene therapy for the deadly diseases ...

Doctors have announced the first successful treatment for Huntington’s disease, a devastating inherited condition that combines symptoms of dementia, Parkinson’s and motor neurone disease. The ...

Levothyroxine is one of the most commonly prescribed medications in the United States. It’s used to treat thyroid problems, especially hypothyroidism, which happens when the thyroid gland doesn’t make ...

Millions of Americans have thyroid disorders, but up to 60 percent don’t know it. From subtle tremors to creeping brain fog, here’s what doctors say you shouldn’t ignore. A woman with an enlarged ...